KEMPHARM, INC (115) | Human Resources (15)

Browse by Subcategory

Bonus & Incentive Agreements (2 contracts)
Compensation Agreements (6)
Consulting Agreements (1)
Employment Agreements (4)
Transition Agreements (2)

Recent Contracts

Agreement Regarding Employment Terms, dated as of May 13, 2023, between Zevra Therapeutics, Inc. and Christal M.M. Mickle (Filed With SEC on May 15, 2023)
Transition Agreement, dated as of May 6, 2023, between Zevra Therapeutics, Inc. and Richard W. Pascoe (Filed With SEC on May 8, 2023)
EighthAmended and Restated Non-Employee Director Compensation Policyeffective February 15, 2023 (Filed With SEC on March 7, 2023)
2023 Employment Inducement Award Plan and forms of award agreements thereunder (Filed With SEC on March 7, 2023)
Amendment to Employment Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Richard W. Pascoe (Filed With SEC on January 9, 2023)
Transition Agreement, dated as of January 4, 2023, as amended, between KemPharm, Inc. and Travis C. Mickle, Ph.D (Filed With SEC on January 9, 2023)
Consulting Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Travis C. Mickle, Ph.D (Filed With SEC on January 9, 2023)
Seventh Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 12, 2022)
Executive Employment Agreement by and between the Registrant and Richard W. Pascoe, dated as of November 5, 2021 (Filed With SEC on November 10, 2021)
Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on August 13, 2021)
Sixth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2021)
Fifth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 24, 2020)
Fourth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 14, 2019)
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2014 Equity Incentive Plan (Filed With SEC on May 14, 2019)
Amended Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2019)